Skip to main content

Wednesday, December 16, 2015 Presented by Robert S. Mancini

Robert Mancini, PharmD, BCOP, FHOPA
Clinical Oncology Pharmacist
St. Luke's Mountain States Tumor Institute
Boise, ID
This peer-delivered program, brought to you by Takeda, will include a clinical overview of NINLARO and its product attributes.
Related Items
Protecting Patients with Cancer During the COVID-19 Pandemic
Robert Mancini, PharmD, BCOP, FHOPA, Timothy G. Tyler, PharmD, FCSHP, FHOPA
JHOP - April 2022 Vol 12, No 2 published on April 26, 2022 in Editorial, COVID-19
Inadequate Transdermal Patch Absorption in a Patient with Scleroderma Associated with Graft-versus-Host Disease
Robert Mancini, PharmD, BCOP, FHOPA, Mallori Hooker, NP-C, AOCNP, BMTCN, William Kreisle, MD
JHOP - February 2020 Vol 10, No 1 published on February 19, 2020 in Case Reports, Graft-versus-Host-Disease
Chemotherapy Administration Sequencing: An Update on the Current Literature
Alanna D. Lehman, PharmD, BCOP, Anna Howard, PharmD, BCOP, Robert Mancini, PharmD, BCOP, FHOPA
JHOP - December 2019 Vol 9, No 4 published on December 13, 2019 in Review Article
Comparing Granulocyte Colony-Stimulating Factors Prescribing Practices versus Guideline Recommendations in a Large Community Cancer Center
Kirollos S. Hanna, PharmD, BCPS, BCOP, Robert Mancini, PharmD, BCOP, FHOPA, Dave Wilson, PharmD, Dan Zuckerman, MD
JHOP - September 2019 Vol 9, No 3 published on September 9, 2019 in Practical Issues in Pharmacy Management
Aplastic Anemia in a Patient with Anaplastic Oligodendroglioma Postradiation and Concurrent Temozolomide Therapy: Case Report and Review of the Literature
Kirollos S. Hanna, PharmD, BCPS, BCOP, Robert Mancini, PharmD, BCOP, FHOPA, Matthew Burtelow, MD, PhD, Benjamin Bridges, MD
JHOP - March 2018 Vol 8, No 1 published on March 1, 2018 in Case Reports
Evaluation of the Duration of Oral Chemotherapies Use at a Community Cancer Center
Sarah Hogue, PharmD, Joseph Ineck, PharmD, CPE, Robert Mancini, PharmD, BCOP, FHOPA
JHOP - December 2017 Vol 7, No 4 published on December 8, 2017 in Original Article
The Effect of Written Pharmacist-Provided Patient Education for 3 Frequently Prescribed Oral Anticancer Agents on the Incidence of Patient-Initiated Triage Calls
Nicolas De Padova, PharmD, Robert Grabowski, PharmD, Joseph Ineck, PharmD, CPE, Robert Mancini, PharmD, BCOP, FHOPA
JHOP - Sept 2016 Vol 6, No 3 published on August 22, 2016 in Original Article
Pharmacist-Run Vaccination and Medication Management Service for Patients After Bone Marrow Transplant
Robert Mancini, PharmD, BCOP, FHOPA, Simon Pence, PharmD
JHOP - March 2015 Vol 5, No 1 published on March 17, 2015 in Original Article
Pharmacist Assessment of Polypharmacy Risks in Patients with Cancer
Robert Mancini, PharmD, BCOP, FHOPA, Kathleen Clifford, MSN, FNP-BC, AOCNP, ACHPN
JHOP - March 2013 VOL 3, NO 1 published on March 18, 2013 in Original Article
Impact of a Pharmacist-Managed Oral Chemotherapy Program on Nonfulfillment Rates
Robert Mancini, PharmD, BCOP, FHOPA, April Sondag, PharmD, Kaylee Drenker, PharmD
JHOP - June 2012, Vol 2, No 2 published on July 3, 2012 in Practical Issues in Pharmacy Management